Euroasian journal of hepato-gastroenterology · 2026
Characteristics and Prognostic Factors of Hepatitis B Virus-associated Hepatocellular Carcinoma in Patients with and without Cirrhosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tekin İbrahim E, Simsek Cem, Balaban Hatice Y, Dag Osman, Şimşek Halis
Аннотация
AIMS AND BACKGROUND: This study aimed to evaluate and compare the factors affecting survival in patients with and without cirrhosis who developed hepatocellular carcinoma (HCC) on the background of hepatitis B virus (HBV).
MATERIALS AND METHODS: In our retrospective, single-center study, the data of 114 patients who were admitted to our center between January 2012 and January 2021 and who met the inclusion criteria were collected. Factors affecting survival were identified by log-rank and Cox regression analysis. Data of patients with and without cirrhosis were compared.
RESULTS: Patients with and without cirrhosis were compared; 64 (56.1%) patients had cirrhosis and it was associated with reduced survival (17 vs 34 months, p = 0.02). Better survival was observed with increased body mass index (BMI) level in non-cirrhotic HCC [Hazard ratio (HR): 0.84, p = 0.005] whereas no effect on patients with cirrhotic HCC (HR: 0.97, p = 0.51). Hypertension rate was higher in the non-cirrhotic patient group (48% vs 20.3%, p = 0.002) but it was not associated with survival in either group.
CONCLUSION: Prolonged survival was observed with increased BMI levels in patients with non-cirrhotic HCC, even though BMI levels did not differ in both groups (p = 0.39). Considering the absence of cirrhosis in 30-50% of HBV-associated HCC cases, further studies are needed for the survival effects of metabolic factors in patients with non-cirrhotic HCC.
CLINICAL SIGNIFICANCE: Our findings suggest that metabolic factors such as BMI and hypertension may influence the clinical course of HBV-related HCC, especially in non-cirrhotic patients. Recognizing these factors could help identify patients at risk and guide tailored management strategies.
HOW TO CITE THIS ARTICLE: Tekin İE, Simsek C, Balaban HY, et al. Characteristics and Prognostic Factors of Hepatitis B Virus-associated Hepatocellular Carcinoma in Patients with and without Cirrhosis. Euroasian J Hepato-Gastroenterol 2025;15(2):208-212.
MATERIALS AND METHODS: In our retrospective, single-center study, the data of 114 patients who were admitted to our center between January 2012 and January 2021 and who met the inclusion criteria were collected. Factors affecting survival were identified by log-rank and Cox regression analysis. Data of patients with and without cirrhosis were compared.
RESULTS: Patients with and without cirrhosis were compared; 64 (56.1%) patients had cirrhosis and it was associated with reduced survival (17 vs 34 months, p = 0.02). Better survival was observed with increased body mass index (BMI) level in non-cirrhotic HCC [Hazard ratio (HR): 0.84, p = 0.005] whereas no effect on patients with cirrhotic HCC (HR: 0.97, p = 0.51). Hypertension rate was higher in the non-cirrhotic patient group (48% vs 20.3%, p = 0.002) but it was not associated with survival in either group.
CONCLUSION: Prolonged survival was observed with increased BMI levels in patients with non-cirrhotic HCC, even though BMI levels did not differ in both groups (p = 0.39). Considering the absence of cirrhosis in 30-50% of HBV-associated HCC cases, further studies are needed for the survival effects of metabolic factors in patients with non-cirrhotic HCC.
CLINICAL SIGNIFICANCE: Our findings suggest that metabolic factors such as BMI and hypertension may influence the clinical course of HBV-related HCC, especially in non-cirrhotic patients. Recognizing these factors could help identify patients at risk and guide tailored management strategies.
HOW TO CITE THIS ARTICLE: Tekin İE, Simsek C, Balaban HY, et al. Characteristics and Prognostic Factors of Hepatitis B Virus-associated Hepatocellular Carcinoma in Patients with and without Cirrhosis. Euroasian J Hepato-Gastroenterol 2025;15(2):208-212.